| |
|
|
|
Oramed Pharmaceuticals Inc.  
|
|
3.3 0 (0%) |
05-28 16:00 |
|
Open: |
3.33 |
Pre close: |
3.3 |
Target:
|
4.27
|
|
High: |
3.44 |
Low: |
3.25 |
Resistance:
|
3.66
4.27
|
|
Volume: |
51,196 |
Market Cap: |
77M |
Support:
|
3.10
2.76
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.32
 |
MACD |
MACD(12,26):
|
0.04  |
|
MA(20): |
3.25 |
Signal(12,26,9): |
0.04 |
|
MA(100): |
3.88 |
Stochastic Oscillator |
%K(14,3):
|
47.53 |
|
MA(250): |
3.68 |
%D(3): |
52.80 |
|
Average Volume(K) |
3-Month: |
10547
|
52-Week |
High:
|
6.05 |
|
10-Days: |
6783 |
Low: |
2.32 |
|
RSI |
RSI(14):
|
52.61 |
Change(%): |
10.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.717 |
Return on Equity (ttm) |
-60.7 |
Shares Out. (M) |
23.27 |
|
EPS Est. Current Year |
-0.780 |
Return on Assets (ttm) |
-22.5 |
Shares Float (M) |
20.24 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
13.06 |
|
EPS Est. Next Quarter |
-0.270 |
Qtrly Rev. Growth |
1.2 |
% Held by Institutions |
12.18 |
|
Forward EPS |
0.820 |
Gross Profit (p.s.) |
0.112 |
Shares Short (K) |
160 |
|
Book Value (p.s.) |
0.700 |
EBITDA (p.s.) |
-0.554 |
P/E |
-4.60 |
|
Sales Per Share |
0.116 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.71 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.55 |
P/S |
28.34 |
|
Operating Margin |
-475.43 |
Levered Free Cash Flow
(M) |
-6.67 |
P/CF |
-5.67 |
|
|
|
|
|
|
